Search

Your search keyword '"Michael L. Haas"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Michael L. Haas" Remove constraint Author: "Michael L. Haas" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
21 results on '"Michael L. Haas"'

Search Results

1. Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial

2. Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study

3. Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy

4. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203

5. Quality-Adjusted Survival in Women with Gynecologic Malignancies Receiving IMRT after Surgery: A Patient Reported Outcome Study of RTOG 1203

6. IMRT Improves Late Toxicity Compared to Conventional RT: An Update on NRG Oncology-RTOG 1203

7. Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck

8. Expression Analysis of Human HL60 Cells Exposed to 60 Hz Square- or Sine-Wave Magnetic Fields

9. Utility of radiation in the prevention of heterotopic ossification following repair of traumatic acetabular fracture

10. Clinicians Underreport Adverse Events in NRG Oncology's Radiation Therapy Oncology Group 1203: The Importance of Using Patient-Reported Outcomes in Oncology Clinical Trials

11. A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy

12. The Effects of Target Salience in Operant Feature Positive Discriminations

14. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck

15. Eliminating Complex Treatment Setup for Intact Breast or Postmastectomy Treatment with Intensity Modulated Radiation Therapy

16. Predictive Value of Tumor Recurrence using Urinary Vascular Endothelial Growth Factor Levels in Patients Receiving Radiation Therapy for Glioblastoma

17. In response to Dr. Ochel

18. 9 Radiation therapy with concurrent weekly carboplatin and paclitaxel in advanced stage unresectable squamous cell carcinomas of the head and neck

20. Commercial applications (panel)

21. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.

Catalog

Books, media, physical & digital resources